Article
Association of the protein C promoter CG haplotype and the factor II G20210A mutation is a risk factor for cerebral venous thrombosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Oct 2005
Le Cam-Duchez Véronique, Bagan-Triquenot Aude, Ménard Jean-François, Mihout Bruno, Borg Jeanne-Yvonne
Abstract excerpt
The factor II G20210A mutation and estrogen treatment are described as risk factors for cerebral venous thrombosis (CVT). We evaluated these known risk factors in a population of CVT patients and investigated the role of a combination of two polymorphisms in the promoter of the protein C gene (PC promoter CG haplotype), newly described as risk factors for deep venous thrombosis. A retrospective population of 26...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
